KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $776.0 million.

  • AbbVie's Gains from Investment Securities fell 4277.29% to $776.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year increase of 346.95%. This contributed to the annual value of $3.8 billion for FY2024, which is 2646.26% down from last year.
  • Latest data reveals that AbbVie reported Gains from Investment Securities of $776.0 million as of Q3 2025, which was down 4277.29% from $2.8 billion recorded in Q2 2025.
  • AbbVie's Gains from Investment Securities' 5-year high stood at $3.5 billion during Q4 2022, with a 5-year trough of -$1.6 billion in Q3 2022.
  • For the 5-year period, AbbVie's Gains from Investment Securities averaged around $1.0 billion, with its median value being $1.4 billion (2024).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 176326.53% in 2022, then skyrocketed by 1685000.0% in 2024.
  • AbbVie's Gains from Investment Securities (Quarter) stood at $232.0 million in 2021, then skyrocketed by 1421.55% to $3.5 billion in 2022, then crashed by 51.95% to $1.7 billion in 2023, then tumbled by 83.55% to $279.0 million in 2024, then surged by 178.14% to $776.0 million in 2025.
  • Its Gains from Investment Securities stands at $776.0 million for Q3 2025, versus $2.8 billion for Q2 2025 and $1.5 billion for Q1 2025.